- Home
- ERAS vs FPH Comparison
ERAS vs FPH Comparison
Compare ERAS & FPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERAS
- FPH
- Stock Information
- Founded
- ERAS 2018
- FPH 2009
- Country
- ERAS United States
- FPH United States
- Employees
- ERAS N/A
- FPH N/A
- Industry
- ERAS Biotechnology: Pharmaceutical Preparations
- FPH Real Estate
- Sector
- ERAS Health Care
- FPH Finance
- Exchange
- ERAS Nasdaq
- FPH Nasdaq
- Market Cap
- ERAS 439.7M
- FPH 390.0M
- IPO Year
- ERAS 2021
- FPH 2017
- Fundamental
- Price
- ERAS $2.32
- FPH $6.00
- Analyst Decision
- ERAS Buy
- FPH
- Analyst Count
- ERAS 6
- FPH 0
- Target Price
- ERAS $3.83
- FPH N/A
- AVG Volume (30 Days)
- ERAS 1.7M
- FPH 144.6K
- Earning Date
- ERAS 11-11-2025
- FPH 10-23-2025
- Dividend Yield
- ERAS N/A
- FPH N/A
- EPS Growth
- ERAS N/A
- FPH 46.82
- EPS
- ERAS N/A
- FPH 1.08
- Revenue
- ERAS N/A
- FPH $197,429,000.00
- Revenue This Year
- ERAS N/A
- FPH N/A
- Revenue Next Year
- ERAS N/A
- FPH N/A
- P/E Ratio
- ERAS N/A
- FPH $5.65
- Revenue Growth
- ERAS N/A
- FPH N/A
- 52 Week Low
- ERAS $1.01
- FPH $3.42
- 52 Week High
- ERAS $3.31
- FPH $6.71
- Technical
- Relative Strength Index (RSI)
- ERAS 68.53
- FPH 50.11
- Support Level
- ERAS $1.78
- FPH $5.92
- Resistance Level
- ERAS $2.65
- FPH $6.14
- Average True Range (ATR)
- ERAS 0.20
- FPH 0.19
- MACD
- ERAS 0.05
- FPH -0.03
- Stochastic Oscillator
- ERAS 68.34
- FPH 11.72
About ERAS Erasca Inc.
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's product pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.
About FPH Five Point Holdings LLC
Five Point Holdings LLC is an owner and developer of mixed-use, master-planned communities in California. It is engaged in developing new communities that, in addition to homesites, include commercial, retail, educational, and recreational elements, as well as civic areas, parks, and open spaces. Its three reportable segments are Valencia, San Francisco, and Great Park. It derives the majority of revenue from the Great Park segment which includes Great Park Neighborhoods being developed adjacent to and around the Orange County Great Park, a metropolitan park under construction in Orange County, California.